| Literature DB >> 35883864 |
Yunju Yin1,2, Yating Liu1, Geyan Duan2,3, Mengmeng Han2,3, Saiming Gong1,2, Zhikang Yang1, Yehui Duan2, Qiuping Guo2, Qinghua Chen1, Fengna Li2.
Abstract
This study examined the effects of dietary leucine supplements on antioxidant capacity and meat quality in growing-finishing pigs. A total of 24 crossbred (Duroc × Landrace × Yorkshire) pigs with an average initial weight of 68.33 ± 0.97 kg were randomly allotted to three treatment groups. All pigs were exposed to constant heat stress. Each group of pigs was fed a basal diet, or a diet supplemented with increasing levels of leucine (0.25% or 0.50%). The results showed that leucine intake could improve average daily gain and reduce feed/gain of finishing pigs under heat stress (p < 0.05). The supplementation of leucine could improve the carcass slant length (p = 0.09), and dramatically increased loin-eye area of the finishing pigs (p < 0.05) but had no significant effect on other carcass traits. Compared with the control group, 0.50% leucine markedly reduced drip loss and shear force of longissimus dorsi muscle, and increased pH value at 24 h after slaughter (p < 0.05). Dietary supplementation of 0.25% leucine increased the contents of inosine monophosphate and intramuscular fat in biceps femoris muscle (p < 0.05). Supplementation of 0.25% or 0.50% leucine significantly stimulated the activities of antioxidant enzymes while reduced the level of MDA in serum, liver and longissimus dorsi muscle (p < 0.05). Compared with the control group, 0.50% leucine supplementation markedly modulated the relative mRNA expression levels of genes related to muscle fiber type and mitochondrial function in longissimus dorsi muscle and the gene relative antioxidant in the liver (p < 0.05). In conclusion, dietary leucine supplementation could improve the growth performance and meat quality of the finishing pigs under heat stress, and the pathway of Keap1-NRF2 and PGC-1α-TFAM might be involved.Entities:
Keywords: antioxidant; growing-finishing pigs; leucine; meat quality
Year: 2022 PMID: 35883864 PMCID: PMC9312205 DOI: 10.3390/antiox11071373
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Ingredients and nutritional composition of basic diets (low protein diet).
| Ingredients (%) | Leucine Levels % | ||
|---|---|---|---|
| 0 | 0.25 | 0.50 | |
| Corn | 79.42 | 80.00 | 80.36 |
| Soybean meal | 14.80 | 13.88 | 13.20 |
| Wheat bran | 3.00 | 3.00 | 3.00 |
| Lysine | 0.28 | 0.30 | 0.32 |
| Methionine | 0.00 | 0.01 | 0.02 |
| Threonine | 0.07 | 0.08 | 0.09 |
| Tryptophan | 0.01 | 0.02 | 0.02 |
| Leucine | 0.00 | 0.25 | 0.50 |
| Isoleucine | 0.00 | 0.02 | 0.02 |
| Valine | 0.00 | 0.01 | 0.03 |
| CaHPO4 | 0.60 | 0.60 | 0.60 |
| Limestone | 0.52 | 0.53 | 0.54 |
| Salt | 0.30 | 0.30 | 0.30 |
| Premix 1 | 1.00 | 1.00 | 1.00 |
| Total | 100.00 | 100.00 | 100.00 |
| Nutrient content (%) | |||
| Metabolic Energy, ME (MJ/kg) 2 | 12.73 | 12.70 | 12.66 |
| Crude Protein | 13.58 | 13.69 | 13.88 |
| SID Lysine 2 | 0.74 | 0.73 | 0.73 |
| SID (Methionine + Cysteine) | 0.42 | 0.42 | 0.42 |
| SID Threonine | 0.47 | 0.47 | 0.47 |
| SID Tryptophan | 0.13 | 0.14 | 0.13 |
| SID Leucine | 1.12 | 1.34 | 1.57 |
| Total Ca | 0.51 | 0.46 | 0.48 |
| Total P | 0.59 | 0.50 | 0.56 |
1 Supplied per kg of diet: vitamin A, 6000 IU; vitamin D3, 4000 IU; vitamin E, 40 IU; vitamin K3, 4 mg; vitamin B1, 6 mg; vitamin B2, 12 mg; vitamin B6, 6 mg; vitamin B12, 0.05 mg; biotin, 0.2 mg; folic acid, 2 mg; niacin, 50 mg; D-calcium pantothenate, 25 mg; Cu (as copper sulfate), 150 mg; Fe (as ferrous sulfate), 100 mg; Mn (as manganese oxide), 40 mg; Zn (as zinc oxide), 100 mg; I (as potassium iodide), 0.5 mg; and Se (as sodium selenite), 0.3 mg. 2 Calculated value for ME and SID amino acids. SID: standardized ileal digestible.
Figure 1Temperature and humidity in the piggery during the experimental period.
Primers used for quantitative real-time PCR.
| Genes 1 | Primers | Sequences (5′ to 3′) | Product Size, bp |
|---|---|---|---|
| NRF2 | Forward | GAAAGCCCAGTCTTCATTGC | 121 |
| Reverse | TTGGAACCGTGCTAGTCTCA | ||
| Keap1 | Forward | GCCTCATCGAGTTCGCTTAC | 105 |
| Reverse | CACGGACCACACTGTCAATC | ||
| NQO1 | Forward | GTATCCTGCCGAGACTGCTC | 134 |
| Reverse | TAGCAGGGACTCCAAACCAC | ||
| MyHC I | Forward | GGCCCCTTCCAGCTTGA | 114 |
| Reverse | TGGCTGCGCCTTGGTTT | ||
| MyHC IIa | Forward | TTAAAAAGCTCCAAGAACTGTTTCA | 136 |
| Reverse | CCATTTCCTGGTCGGAACTC | ||
| MyHC IIb | Forward | CACTTTAAGTAGTTGTCTGCCTTGAG | 80 |
| Reverse | GGCAGCAGGGCACTAGATGT | ||
| MyHC IIx | Forward | AGCTTCAAGTTCTGCCCCACT | 76 |
| Reverse | GGCTGCGGGTTATTGATGG | ||
| MyoD | Forward | AAGTCAACGAGGCCTTCGAG | 123 |
| Reverse | GGGGGCCGCTATAATCCATC | ||
| MyoG | Forward | AGGCTACGAGCGGACTGA | 123 |
| Reverse | GCAGGGTGCTCCTCTTCA | ||
| MAFbx | Forward | CCCTCTCATTCTGTCACCTTG | 104 |
| Reverse | ATGTGCTCTCCCACCATAGC | ||
| MuRF1 | Forward | AGCACGAAGACGAGAAAATC | 150 |
| Reverse | TGCGGTTACTCAGCTCAGTC | ||
| PGC-1α | Forward | CCCGAAACAGTAGCAGAGACAAG | 111 |
| Reverse | CTGGGGTCAGAGGAAGAGATAAAG | ||
| SIRT1 | Forward | ACTCTCCCTCTTTTAGACCAAGC | 149 |
| Reverse | AAACCTGGACTCTCCATCGG | ||
| NRF1 | Forward | CCTTGTGGTGGGAGGAATGTT | 152 |
| Reverse | AGTATGCTGGCTGACCTTGTG | ||
| TFAM | Forward | GGTCCATCACAGGTAAAGCTGAA | 167 |
| Reverse | ATAAGATCGTTTCGCCCAACTTC | ||
| UCP2 | Forward | CTTCTGCGGTTCCTCTGTGT | 260 |
| Reverse | CATAGGTCACCAGCTCAGCA | ||
| AMPKα | Forward | GCATAGTTGGGTGAGCCACA | 105 |
| Reverse | CCTGCTTGATGCACACATGA | ||
| GAPDH | Forward | ACTCACTCTTCTACCTTTGATGCT | 123 |
| Reverse | TGTTGCTGTAGCCAAATTCA |
1 NRF2: nuclear factor E2-related factor 2, Keap1: Kelch-like ECH-associated protein-1, NQO1: NAD (P)H: quinone oxidoreductase 1, MyHC I: myosin heavy chain I, MyHC IIa: myosin heavy chain IIa, MyHC IIx: myosin heavy chain IIx, MyHC IIb: myosin heavy chain Iib, MyoD: Myogenic Differentiation Antigen, myoG: myoglobin, MAFbx: muscle atrophy F-box,MuRF1: Muscle RING finger 1, PGC-1α: peroxlsome proliferator—activated receptor-γ coactlvator-1α, SIRT1: Silent information regulator 1, NRF1: nuclear factor E2-related factor 1, TFAM: Recombinant Transcription Factor A, Mitochondrial, UCP2: uncoupling protein 2, AMPKα: adenine monophosphate activated protein kinase α.
Growth performance of finishing pigs fed the diets with various levels of Leucine.
| Item 1 | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| Initial weight, kg | 69.57 | 67.76 | 67.57 | 1.74 | 0.67 |
| Final weight, kg | 88.70 | 93.23 | 91.58 | 1.56 | 0.07 |
| ADG, Kg·d−1 | 0.42 b | 0.61 a | 0.59 a | 0.04 | <0.01 |
| ADFI, Kg·d−1 | 2.26 | 2.46 | 2.24 | 0.16 | 0.55 |
| F/G | 3.95 a | 3.20 b | 3.17 b | 0.16 | <0.01 |
a,b Different superscript letters on the same line are significant differences (p < 0.05). 1 ADG: average daily weight gain, ADFI: average daily feed intake, F/G: the ratio of feed intake to body weight gain.
Carcass trait of finishing pigs fed the diets with various levels of leucine.
| Item | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.5 | |||
| Carcass weight, kg | 55.87 | 58.82 | 58.92 | 1.73 | 0.38 |
| Slaughter rate, % | 64.27 | 65.77 | 65.62 | 0.04 | 0.43 |
| Carcass straight length, cm | 87.11 | 87.86 | 89.41 | 1.16 | 0.39 |
| Carcass slant length, cm | 71.76 b | 74.90 a | 75.03 a | 0.10 | 0.09 |
| Average backfat | 20.69 a | 16.34 b | 16.29 b | 1.07 | 0.01 |
| Loin-eye area, cm2 | 30.06 b | 34.30 a,b | 36.22 a | 1.54 | 0.03 |
| Lean mass percentage, % | 59.78 | 60.66 | 61.07 | 0.52 | 0.22 |
| Total fat rate percentage, % | 15.67 | 14.00 | 15.57 | 0.52 | 0.21 |
a,b Different superscript letters on the same line are significant differences (p < 0.05).
Effects of dietary leucine on meat quality of finishing pigs.
| Item | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| After slaughter 45 min | |||||
| pH | 6.51 | 6.51 | 6.48 | 0.04 | 0.80 |
| L* | 47.08 | 47.54 | 47.78 | 0.54 | 0.65 |
| a* | 13.97 | 13.86 | 13.77 | 0.15 | 0.64 |
| b* | 5.66 | 5.67 | 5.82 | 0.15 | 0.72 |
| After slaughter 24 h | |||||
| pH | 5.23 b | 5.28 a,b | 5.34 a | 0.03 | 0.03 |
| L* | 55.44 | 55.92 | 56.23 | 0.74 | 0.75 |
| a* | 14.85 | 14.81 | 14.75 | 0.23 | 0.96 |
| b* | 8.10 | 8.14 | 8.41 | 0.22 | 0.57 |
| Drip loss (%) | 28.93 a | 23.44 b | 23.43 b | 0.82 | <0.01 |
| Shear force (N) | 47.23 a | 42.06 b | 37.60 b | 1.63 | <0.01 |
a,b Different superscript letters on the same line are significant differences (p < 0.05).
Effects of dietary leucine on chemical composition of the muscle tissue.
| Item 1 | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| CP % | 15.81 | 16.70 | 16.39 | 0.67 | 0.56 |
| IMF % | 2.24 | 2.21 | 2.15 | 0.16 | 0.92 |
| IMP | 1.84 | 2.00 | 2.04 | 0.14 | 0.58 |
| CP % | 16.07 | 16.13 | 16.38 | 0.82 | 0.96 |
| IMF % | 1.79 b | 2.66 a | 2.10 b | 0.17 | <0.01 |
| IMP | 2.11 b | 2.56 a | 2.19 b | 0.104 | 0.01 |
a,b Different superscript letters on the same line are significant differences (p < 0.05). 1 IMF, intramuscular fat; IMP, inosine monophosphate, CP: crude protein.
Effects of different levels of leucine on serum antioxidant enzyme activities of finishing pigs.
| Item 1 | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| GSH-Px, U·mL−1 | 128.10 | 139.81 | 141.35 | 5.16 | 0.16 |
| T-AOC, U·mL−1 | 0.87 b | 0.89 ab | 0.90 a | 0.012 | 0.08 |
| SOD, U·mL−1 | 109.90 b | 140.51 a | 143.40 a | 8.13 | 0.01 |
| CAT, U·mL−1 | 10.28 c | 13.83 a | 11.91 b | 0.39 | <0.01 |
| MDA, nmol·mL−1 | 9.60 a | 6.19 c | 8.18 b | 0.38 | <0.01 |
a–c Different superscript letters on the same line are significant differences (p < 0.05). 1 GSH-Px: Glutathione peroxidase, T-AOC: Total antioxidant capacity, SOD: Superoxide dismutase, CAT: Catalase, MDA: Malondialdehyde.
Effects of different levels of leucine on liver antioxidant enzyme activities of finishing pigs.
| Item 1 | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| GSH-Px, U·mL−1 | 128.10 | 139.81 | 141.35 | 5.16 | 0.16 |
| T-AOC, U·mL−1 | 0.87 b | 0.89 a,b | 0.90 a | 0.012 | 0.08 |
| SOD, U·mL−1 | 109.90 b | 140.51 a | 143.40 a | 8.13 | 0.01 |
| CAT, U·mL−1 | 10.28 c | 13.83 a | 11.91 b | 0.39 | <0.01 |
| MDA, nmol·mL−1 | 9.60 a | 6.19 c | 8.18 b | 0.38 | <0.01 |
a–c Different superscript letters on the same line are significant differences (p < 0.05). 1 GSH-Px: Glutathione peroxidase, T-AOC: Total antioxidant capacity, SOD: Superoxide dismutase, CAT: Catalase, MDA: Malondialdehyde.
Effects of different levels of leucine on Longissimus dorsal muscles antioxidant enzyme activities of finishing pigs.
| Item 1 | Leucine Levels % | SEM | |||
|---|---|---|---|---|---|
| 0 | 0.25 | 0.50 | |||
| GSH-Px, U·mL−1 | 148.01 b | 164.22 a,b | 177.94 a | 7.17 | 0.04 |
| T-AOC, U·mL−1 | 0.88 b | 0.92 a | 0.92 a | 0.01 | <0.01 |
| SOD, U·mL−1 | 136.80 b | 172.24 a | 156.96 a,b | 6.88 | <0.01 |
| CAT, U·mL−1 | 16.12 b | 16.44 a,b | 17.36 a | 0.34 | 0.05 |
| MDA, nmol·mL−1 | 10.79 a | 8.06 b | 8.83 b | 0.48 | <0.01 |
a,b Different superscript letters on the same line are significant differences (p < 0.05). 1 GSH-Px: Glutathione peroxidase, T-AOC: Total antioxidant capacity, SOD: Superoxide dismutase, CAT: Catalase, MDA: Malondialdehyde.
Figure 2Relative mRNA expression levels of key genes related to antioxidant capacity in liver. Leu: Leucine. a–c Different superscript letters on the same line are significant differences (p < 0.05).
Figure 3Relative mRNA expression levels of f key genes related to muscle fiber growth in longissimus dorsi muscle. Leu: Leucine. a,b Different superscript letters on the same line are significant differences (p < 0.05).
Figure 4Relative mRNA expression levels of key genes related to mitochondrial function in longissimus dorsi muscle. Leu: Leucine. a,b Different superscript letters on the same line are significant differences (p < 0.05).
Figure 5Mechanism of leucine regulating meat quality of finishing pigs under heat stress. Leucine enters muscle cells and activates the gene expression levels of AMPKα, AMPKα activates the expression level of SIRT1, which then activates the expression of UCP2, thereby inhibiting the production of mitochondrial ROS. In addition, AMPK also activates PGC-1α, which entering the nucleus to promote the expression of NRF1 transferred to mitochondria to promote the expression of TFAM and improve the muscle injury caused by heat stress, then improve the meat quality. Leucine enters liver cells and promotes the separation of keap1-NRF2. When NRF2 is released, it was transferred to the nucleus and combined with ARE to activate the expression level of downstream NQO1 gene, inhibiting the production of ROS, and then alleviate the oxidative stress caused by high temperature, ultimately improving the meat quality.